Valeant Pharmaceuticals Receives Notice Of Default From Bondholders Due To Delayed 10-K Filing

Notice Does Not Accelerate Any of the Company’s Indebtedness

Company Has Until June 11, 2016 to Cure Default By Filing 10-K

Company is on Schedule to File its 10-K on or before April 29, 2016, as Previously Disclosed

LAVAL, Quebec, April 12, 2016 /PRNewswire/ — Valeant…